文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > Epigenetic GABAergic Targets in Schizophrenia and Bipolar
侵权投诉

Epigenetic GABAergic Targets in Schizophrenia and Bipolar

Introduction

This review summarizes our present understanding of the topic of neuroepigenetics in major

psychotic disorders. To elucidate the molecular mechanisms whereby nurture (biological or

environmental epigenetic factors) and nature (genetic factors) interact to cause major

psychiatric disorders such as schizophrenia (SZ) and bipolar (BP) disorder was at the center

of Dr. Costa’s mission for the last 15 years of his research at the Psychiatric Institute at the

University of Illinois at Chicago (Costa et al., 2002).

Existing drugs used to treat major psychiatric disorders have limited efficacy and substantial

side effects. Hence, the challenge for Dr. Costa and his colleagues has been to find new

ways to prevent and treat psychiatric disorders with pharmacological agents that fail to have

major unwanted side effects.NIH-PA Author Manuscript

NIH-PA Author Manuscript

NIH-PA Author ManuscriptThe challenge to identify the core pathophysiological mechanismsunderlying schizophrenia (SZ) and bipolar (BP) disorder that are targetedby antipsychoticsUnfortunately, there are few new leads for future drug development for the treatment ofmajor psychiatric disorders (Miller, 2010a). A fundamental barrier to the identification ofmore efficacious, less toxic, and faster acting drugs than those presently available to treat BPdisorder and SZ is the incomplete understanding of the etiopathogenetic mechanismsunderlying the symptomatology of these diseases.Population, family, and twin studies indicate that SZ and BP disorders are highly heritable

but a single allele conferring increased risk has been identified in only a small proportion of

the observed phenotypic variants (Li, 2010, Sullivan et al., 2008). Hence, the hypothesis that

complex psychiatric disorders are attributable to a relatively few common genetic variants

has been questioned. Rather, it appears that these disorders are the consequence of

synergistic interactions of multiple susceptibility genes with environmental neuroepigenetic

factors (Ptak and Petronis, 2008).

“Neuroepigenetics” refers to the reversible regulation of various genomic functions

mediated principally through changes in DNA methylation and chromatin structure in

neurons.

The findings reviewed in this article marshaled by the pioneering work of Costa and his

collaborators (1996–2010) suggest that an epigenetic downregulation of telencephalic

GABAergic genes may represent a contributing factor to the behavioral and cognitive

impairments experienced by SZ and BP disorder patients.

Despite the large number of pharmacological studies performed in recent years to delineate

the receptor affinity profile of different antipsychotics (Table 1) (Gary and Roth 2007,

Jarskog et al. 2007, Roth et al. 2004), little is known about the action of antipsychotics on

specific epigenetic mechanisms in GABAergic or glutamatergic neurons. In fact, the

上一页第2页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email